Monovisc is a single, intraarticular injection of cross-linked sodium hyaluronate designed to treat the symptoms of osteoarthritis. It is manufactured from ultra-pure, high molecular weight sodium hyaluronate produced by bacterial fermentation. Monovisc is indicated as a viscosupplement or as a replacement for synovial fluid in human joints. It is well suited for the treatment of the symptoms of human joint dysfunctions, such as osteoarthritis.
This is the last line in the description
